Pages that link to "Q44007089"

The following pages link to In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications (Q44007089):

Displaying 44 items.

• Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases (Q27025187) (← links)
• Antibody-targeted radiation cancer therapy (Q28264580) (← links)
• Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72 (Q28272255) (← links)
• Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft model (Q33625341) (← links)
• Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials. (Q33661325) (← links)
• Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607. (Q33884461) (← links)
• Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice (Q33925383) (← links)
• Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma. (Q34077332) (← links)
• Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands (Q34160678) (← links)
• Towards translation of 212Pb as a clinical therapeutic; getting the lead in! (Q35028126) (← links)
• In Vitro and In Vivo Pre-Clinical Analysis of a F(ab')(2) Fragment of Panitumumab for Molecular Imaging and Therapy of HER1 Positive Cancers (Q35162293) (← links)
• Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease (Q35650273) (← links)
• Monoclonal antibodies for brain tumour treatment (Q35873775) (← links)
• Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer (Q36451556) (← links)
• A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules (Q36593424) (← links)
• Targeted alpha-therapy: past, present, future? (Q36691184) (← links)
• Preparation & in vitro evaluation of ⁹⁰Y-DOTA-rituximab (Q36769707) (← links)
• Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients (Q36817119) (← links)
• Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies (Q36881146) (← links)
• A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies (Q36908712) (← links)
• Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules (Q36922818) (← links)
• Bifunctional chelates for metal nuclides (Q37017010) (← links)
• Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands (Q37145574) (← links)
• H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy (Q37209655) (← links)
• Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. (Q37364790) (← links)
• Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent (Q37395272) (← links)
• Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (Q37689802) (← links)
• Bismuth compounds in medicinal chemistry. (Q38031636) (← links)
• Radioimmunotherapy for high-grade glioma (Q38110937) (← links)
• Matching chelators to radiometals for radiopharmaceuticals (Q38156660) (← links)
• Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease (Q38663041) (← links)
• High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab. (Q38837764) (← links)
• The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumab. (Q39182026) (← links)
• Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators (Q39376122) (← links)
• Preclinical Evaluation of 177Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor–Overexpressing Tumors (Q39516674) (← links)
• 177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi (Q39632700) (← links)
• Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals (Q39697612) (← links)
• New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology (Q40098290) (← links)
• Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins (Q44538103) (← links)
• H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions (Q46314544) (← links)
• Efficient route to pre-organized and linear polyaminopolycarboxylates: Cy-TTHA, Cy-DTPA and mono/di- reactive, tert-butyl protected TTHA/Cy-TTHA. (Q49613737) (← links)
• 177Lu-labeled-VG76e monoclonal antibody in tumor angiogenesis: A comparative study using DOTA and DTPA chelating systems (Q58211803) (← links)
• Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo (Q60933040) (← links)
• Radiolabeled F(ab')2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models (Q88733503) (← links)